WallStSmart

Alcon AG (ALC)vsAptarGroup Inc (ATR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alcon AG generates 175% more annual revenue ($10.63B vs $3.87B). ATR leads profitability with a 10.0% profit margin vs 7.7%. ALC appears more attractively valued with a PEG of 1.45. ATR earns a higher WallStSmart Score of 53/100 (C-).

ALC

Buy

51

out of 100

Grade: C-

Growth: 4.7Profit: 4.5Value: 4.0Quality: 6.8
Piotroski: 3/9

ATR

Buy

53

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 4.0Quality: 6.0
Piotroski: 3/9Altman Z: 2.57
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALCSignificantly Overvalued (-24.2%)

Margin of Safety

-24.2%

Fair Value

$63.90

Current Price

$66.14

$2.24 premium

UndervaluedFair: $63.90Overvalued
ATRSignificantly Overvalued (-44.1%)

Margin of Safety

-44.1%

Fair Value

$97.16

Current Price

$113.36

$16.20 premium

UndervaluedFair: $97.16Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALC2 strengths · Avg: 9.5/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

ATR1 strengths · Avg: 8.0/10
Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Areas to Watch

ALC4 concerns · Avg: 3.3/10
P/E RatioValuation
38.7x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
3.7%3/10

ROE of 3.7% — below average capital efficiency

Profit MarginProfitability
7.7%3/10

7.7% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

ATR3 concerns · Avg: 3.0/10
PEG RatioValuation
2.124/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-4.3%2/10

Earnings declined 4.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : ALC

The strongest argument for ALC centers on Price/Book, Debt/Equity. PEG of 1.45 suggests the stock is reasonably priced for its growth.

Bull Case : ATR

The strongest argument for ATR centers on Price/Book. Revenue growth of 10.8% demonstrates continued momentum.

Bear Case : ALC

The primary concerns for ALC are P/E Ratio, Return on Equity, Profit Margin.

Bear Case : ATR

The primary concerns for ATR are PEG Ratio, Piotroski F-Score, EPS Growth.

Key Dynamics to Monitor

ALC carries more volatility with a beta of 0.70 — expect wider price swings.

ATR is growing revenue faster at 10.8% — sustainability is the question.

ALC generates stronger free cash flow (274M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ATR scores higher overall (53/100 vs 51/100) and 10.8% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alcon AG

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Visit Website →

AptarGroup Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

AptarGroup, Inc. offers a range of packaging, dispensing and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectables, and food and beverage markets. The company is headquartered in Crystal Lake, Illinois.

Visit Website →

Want to dig deeper into these stocks?